Viking Therapeutics, Inc. (VKTX)
$33.23-1.95%Close
SELLRECOVERY · day 13
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV41.5%–142.6%
- Market cap
- $3.9B
- Avg volume
- 2.3M
- Beta
- 0.69
- P/E (TTM)
- -7.13
- IV-%ile
- 21
- IV ATM
- 62.6%
- Short % float
- 19.97%
- Days to cover
- 10.5
- SI change
- -2.7%
- 1W
- -1.19%
- 1M
- -4.48%
- 3M
- +7.58%
- YTD
- -6.18%
- vs SPY 1W
- +0.00%
- vs SPY 1M
- -7.81%
- vs SPY 3M
- +5.18%
- vs SPY YTD
- -17.94%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AURABUYAura Biosciences, Inc.RECOVERYQ -3$7.90+1.28%
- AVBPSELLArriVent BioPharma, Inc. Common StockRECOVERYQ 21$28.26-2.95%
- AVLNBUYAvalyn Pharma Inc. Common StockQ 75$37.69-1.77%
- CLYMBUYClimb Bio, Inc.BULLQ 11$16.40-5.09%
- COAGBUYHemab Therapeutics Holdings, Inc. Common StockQ 70$46.67-5.07%
- DFTXSELLDefinium Therapeutics, Inc.RECOVERYQ 27$43.27-3.65%
- ELDNSELLEledon Pharmaceuticals, Inc.RECOVERYQ -11$3.41-1.16%
- ELVNBUYEnliven Therapeutics, Inc.BULLQ 15$61.15+2.22%
- EPRXBUYEupraxia Pharmaceuticals Inc.RECOVERYQ 46$7.28+8.17%
- GHRSBUYGH Research PLCBEARQ 19$28.10-0.81%
- GPCRBUYStructure Therapeutics Inc.RECOVERYQ 27$49.01-0.16%
- IMMXBUYImmix Biopharma, Inc.RECOVERYQ 29$13.61-0.37%
Industry peers
FMP comparable companies · ranked by market cap
- PRAXBUYPraxis Precision Medicines, Inc.$10.5BBULLQ 14$376.38-2.10%
- KYMRBUYKymera Therapeutics, Inc.$10.0BBULLQ 27$121.41+1.04%
- IMVTBUYImmunovant, Inc.$9.0BBULLQ 30$43.71-2.37%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.75+0.11%
- LGNDSELLLigand Pharmaceuticals Incorporated$5.8BBEARQ 14$291.77-2.13%
- ACADBUYACADIA Pharmaceuticals Inc.$5.0BBULLQ 19$29.01+0.51%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
- NAMSSELLNewAmsterdam Pharma Company N.V.$3.1BRECOVERYQ 29$26.90-3.66%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- AAPGSELLAscentage Pharma Group International$1.7BCRISISQ 8$18.20-1.71%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-56.7%
REV YoY-
ROE-94.6%
EPS YoY-
ROA-102.5%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-7.13
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B9.43
P/FCF-
EV/EBITDA-7.03
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.00
ALTMAN Z-
CURR RATIO4.72
ND/EBITDA-
BETA0.69
